MF

Moshe Friedman

Head of Amdocs Ventures

Israel

Invests in

Sectors:

Locations:

  • Min Investment:

    $750,000.00
  • Max Investment:

    $3,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Business Strategy
Product Management
Marketing
Capital Markets
Mergers
Business Development
Banking
Mergers & Acquisitions
Program Management
Operations Management
Financial Modeling
Strategic Initiatives
Strategy
Entrepreneurship
Venture Capital
Leadership
Project Management
Valuation
Finance
Equities

Education

Work Experience

2015

  • Head of Amdocs Ventures

    2018

    Responsible for Amdocs' strategic minority investing. Amdocs Ventures is a thesis led strategic investing vehicle that dives deep into new technologies to become subject matter experts in industries with disruptive potential. After investment, we turn the model on its head by going to work for our portfolio companies ensuing they have access to their target customers, working on product scale and derisking their go to market.

  • Corporate Development Leader

    2015 - 2018

    Responsible for all product-centric acquisitions. 5 acquisitions in 2 years including cVidya (revenue assurance), BriteBill (personalized customer communication), Vindicia (subscription management), Vubiquity (Content aggregation and management) and UXP (identity management) adding hundreds of millions of dollars in revenue and launching Amdocs' Media offering which is today a pillar of the business. Strong partnership and alignment with business line leaders throughout the Amdocs organization.

2024

  • Seed Investor & Board Director

    2024

    GenAI enablement via a semantic data fabric

2023

  • Seed Investor & Board Observer

    2023

    eBPF powered automatic observability and root cause analysis

  • Investor

    2022

2022

  • Investor

    2022

2021

  • Seed Investor and Board Observer

    2021

2020

  • Investor and Board Observer

    2020

  • Seed Investor and Board Observer

    2019

  • Seed Investor & Board Observer

    2019

2019

  • Investor and Board Observer

    2019